Separately, Zacks Investment Research downgraded Vicarious Surgical from a hold rating to a sell rating in a research note on Thursday, May 5th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of Buy and a consensus price target of $11.63.
Vicarious Surgical stock opened at $3.93 on Tuesday. The stock has a 50 day moving average of $4.70 and a 200-day moving average of $7.63. Vicarious Surgical has a 52 week low of $3.05 and a 52 week high of $15.79.
In other Vicarious Surgical news, CTO Sammy Khalifa sold 6,830 shares of the business’s stock in a transaction on Thursday, April 14th. The stock was sold at an average price of $4.08, for a total value of $27,866.40. Following the transaction, the chief technology officer now owns 136,413 shares of the company’s stock, valued at $556,565.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Adam David Sachs sold 8,537 shares of the business’s stock in a transaction on Monday, March 28th. The stock was sold at an average price of $4.23, for a total value of $36,111.51. The disclosure for this sale can be found here. In the last ninety days, insiders sold 35,842 shares of company stock worth $152,359.
Hedge funds have recently added to or reduced their stakes in the company. Nauset Wealth Management. LLC bought a new stake in shares of Vicarious Surgical during the first quarter worth $26,000. Advisor Group Holdings Inc. bought a new stake in shares of Vicarious Surgical during the third quarter worth $27,000. BlackRock Inc. bought a new stake in shares of Vicarious Surgical during the third quarter worth $32,000. Citigroup Inc. bought a new stake in shares of Vicarious Surgical during the fourth quarter worth $47,000. Finally, Wolverine Asset Management LLC raised its position in shares of Vicarious Surgical by 165.7% during the first quarter. Wolverine Asset Management LLC now owns 10,147 shares of the company’s stock worth $51,000 after acquiring an additional 6,328 shares during the last quarter. Institutional investors own 35.25% of the company’s stock.
Vicarious Surgical Company Profile (Get Rating)
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
- Get a free copy of the StockNews.com research report on Vicarious Surgical (RBOT)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.